Financials
- Market Capitalization 17.51 B
- Employee 2 000
- Founded 1992
- CEO Kevin C. Gorman
- Website www.neurocrine.com
- Headquarter Delaware, United States
- FIGI BBG000GJS7C1
- Industry 医薬品メーカー(特殊・ジェネリック)
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
20.27
売上高対価格比率
4.35
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 505 | TAK Takeda Pharmaceutical Company Limited American Depositary Share | 16.49 USD | -0.42% | -2.48% | +3.84% | +16.25% | 25.69 B USD | ||
| 613 | VTRS Viatris Inc. - Common Stock | 16.39 USD | +0.74% | -3.36% | -1.27% | +58.36% | 19.09 B USD | ||
| 788 | ELAN Elanco Animal Health Incorporated Common Stock | 25.15 USD | +1.33% | -0.20% | +1.70% | +12.30% | 12.56 B USD | ||
| 876 | RDY Dr. Reddy's Laboratories Ltd | 12.92 USD | -2.12% | -9.84% | -3.51% | -11.93% | 10.78 B USD |